AMC Media Group has been acquired by Formedics
AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to drive engagement and monetization through their specialty digital properties, has been acquired by Formedics, an HCP community and engagement platform that is home to Physician’s Weekly and OncWeekly.
AMC Media Group offers business development, digital advertising and healthcare publishing services to medical experts across the US. Its mission is to activate peer connections that facilitate HCP learning while helping brands access key audiences.
Formedics is an HCP community and engagement platform that supports and connects healthcare professionals wherever they practice medicine or choose to learn. In addition to its leading HCP network, Formedics’ groundbreaking AI/ML technology unlocks unrivaled healthcare targeting and engagement for pharmaceutical and life science brands. The Formedics properties include Physician’s Weekly, Figure 1, OncWeekly and AMC Media Group.
Oaklins DeSilva+Phillips, one of Oaklins’ TMT teams in New York, served as the exclusive financial advisor to AMC Media Group on the transaction. This transaction emphasizes ODP’s deep sector expertise in advising digital media businesses, specifically those within the healthcare communications and technology industry.
JC Landry
President, AMC Media Group
Talk to the deal team
Jon Guttenberg
Oaklins DeSilva+Phillips
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more